Inactive Instrument

Other languages ArQule, Inc.

Equities

NASDAQ COMPOSITE : Wall Street finit en baisse à l'approche d'une échéance clé pour le commerce	19-12-09
DOW JONES 30 : Wall Street ouvre en légère baisse	19-12-09
ArQule : Merck & Co verstärkt sich für 2,7 Mrd Dollar in der Krebsmedizin	19-12-09
US-Pharmakonzern Merck & Co will Krebsspezialisten Arqule übernehmen	19-12-09
USA-Les valeurs à suivre à Wall Street (actualisé)	19-12-09
ArQule, Inc. Provides Financial Guidance for 2019	19-10-30
ArQule, Inc. Provides Financial Guidance for the Fiscal Year 2019	19-08-07
ArQule, Inc. Provides Earnings Guidance for the Year 2019	19-05-01
ArQule, Inc. Provides Earnings Guidance for the Full Year 2019	19-03-07
ArQule, Inc. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2018; Provides Earnings Guidance for the Year 2018	18-08-01
ArQule, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2018; Provides Earnings Guidance for the Year 2018	18-05-07
ArQule, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2017; Provides Earnings Guidance for the Year 2018	18-03-05
ArQule Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2017; Provides Earnings Guidance for the Year 2017	17-11-09
ArQule, Inc. Provides Earnings Guidance for the Year 2016	16-11-07

No results for this search